Gary Novack presents talk on new glaucoma drugs

Dr. Gary Novack presented an invited talk on “Why are there not more new glaucoma drugs” at the August meeting of the Glaucoma Research Society. The Glaucoma Research Society is a public interest, non-profit scientific association of outstanding glaucoma researchers that provides a forum to discuss and stimulate compelling or innovative research to prevent glaucoma-related […]

Dr. Novack presents at UC Davis Ophthalmology Course in Napa

In May, Dr. Novack was part of a UC Davis Department of Ophthalmology & Vision Science weekend Continuing Medical Education course in Napa. He presented issues surrounding off-label use and compounded medications in ophthalmology. He also discussed generic vs. branded products.

Dr. Novack judged UC Davis Ophthalmology Research

Dr. Novack, served as a judge at the UC Davis Department of Ophthalmology & Visual Sciences annual trainee and alumni research day. It was a great day highlighting the quality of our trainees, faculty, alumni and guest speaker, George B. Bartley , M.D.

Dr. Novack featured in “The Ophthalmologist”

Dr. Novack was featured in a spotlight on ARVO members in a May 2022 posting of The Ophthalmologist entitled “Captain’s Log”, the reported focused on Dr. Novack’s answer to a query about an analogy for his work. Novack said “…like Captain James T. Kirk in the Star Trek Original Series “Corbomite Maneuver”, episode, I use […]

Gary Novack presents posters at ARVO 2022 in Denver

Dr. Gary Novack presented two posters at the May 2022 ARVO conference in Denver. One of these was presented in the Cornea section on preclinical data on a new investigative potential treatment for dry eye disease. The other was presented in the retina section on Phase 3 studies of a new topical anesthetic for use […]

60 products!

With a recent product approval, Dr. Novack has now made substantial contributions to 60 approved products during his career…

Value of medical writers discussed in top journal

In a recent article in JAMA Oncology on the use of surrogate endpoints in oncology, del Paggio et al identified industry funding for nearly all.  They further highlighted the use of medical writers in papers published on this work to be of concern…

Dr. Novack’s paper among top 100 glaucoma papers

The American Glaucoma Society recently sought to identify 100 articles with significant impact on the clinical care of patients with glaucoma. This was based upon citation frequency and the input of members of the Society…